Cardiac Ablation Technologies Market (By Technology Type: Radiofrequency, Cryoablation, Laser, Ultrasound, Microwave, Others; By Application: Atrial fibrillation, Ventricular Tachycardia, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global cardiac ablation technologies Market is project worth US$ 3,450.5 Million in 2017 and the market is projected to showcase 11.4% CAGR during the forecast period. The cardiac ablation technologies market is driven by rising incidence of atrial fibrillation and technological advancement.

Market Dynamics

Rising prevalence of atrial fibrillation and increase in adoption of cardiac ablation technologies for the treatment of atrial fibrillation are the driving factors boosting the growth of the cardiac ablation technologies market. Also, increase in patient preference for minimally invasive surgeries and technological advancement creates demand for cardiac ablation technologies which is bolstering the growth of the global cardiac ablation technologies market.

Market Insights

There is huge presence of elderly population in developed countries such as the U.S, and most countries of Europe, and Japan. Developed countries are witnessing high rate of aging as compared to developing nations. This factor is contributing to the rise in improved healthcare infrastructure, favourable government norms, and technological advancements in healthcare facilities in these developed countries. Additionally, ease of access to several diagnostic services has developed in the recent years, particularly in developed countries. This, in turn, has improved the life expectancy of the population in these countries. The aged population are the target user of cardiac ablation technologies as there is higher risk of increasing cardiac diseases.

Market Classification

The global cardiac ablation technologies market is segmented into technology type, application and region. On the basis of technology type, the global cardiac ablation technologies market is segmented into radio frequency, cryoablation, laser, ultrasound, microwave, and others. On the basis of application, the global cardiac ablation technologies market is segmented into atrial fibrillation, ventricular tachycardia, and others. On the basis of region the global cardiac ablation technologies market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Based on technology type, the radiofrequency segment accounted for around 50% share of the global market. The radiofrequency ablation procedure is a well-known procedure that offers high safety and efficiency that leads to higher adoption of these technologies. Moreover, it is a least invasive procedure that has low risk and less pain and is easy to perform which is further contributing to the growth of global cardiac ablation technologies market.

Regional Insights

Increase in patient preference for minimally invasive surgeries and technological advancement creates demand for cardiac ablation technologies which is one of the key factor for the growth of the cardiac ablation technologies market. North America is anticipated to hold major share of the global market, due to higher adoption of cardiac ablation technologies and increase in medical expenditure. Europe is predicted to account for a significant share of the global market during the forecast period. Increase in incidence of atrial fibrillation and other heart diseases is projected to fuel the market growth in the region. The market in Asia Pacific region is expected to grow at a rapid pace due to the rise in healthcare expenditure.

Market Participants

The major players associated with the cardiac ablation technologies market are Medtronic Plc, St. Jude Medical, Inc. (Abbott), Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, CardioFocus Inc., and Biosense Webster, Inc. (Johnson & Johnson),and CONMED Corporation etc. The key players in the cardiac ablation technologies market are constantly focusing on research and development in order to expand their product portfolio and increase their customer base in developing regions.Key manufacturers invests heavily in research and development to manufacture low weighting, fuel efficient and innovative cardiac ablation technologies models. Additionally, players associated with the global cardiac ablation technologies market are focusing mainly on merger and acquisition and developing strategic partnerships with other players in order to expand their product portfolio and to increasethe market share.

Market Segmentation

Market By Technology Type

  • Radiofrequency
  • Cryoablation
  • Laser
  • Ultrasound
  • Microwave
  • Others

Market By Application

  • Atrial fibrillation
  • Ventricular Tachycardia
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary